55 completed. 55 Phase 2, 11 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 55 | Completed 55 |
| Phase 1 | 11 | Completed 11 |
| Phase 3 | 3 | Completed 3 |
Follow Alcohol Drinking: new trials by email Literature Review of Alcohol Drinking trials Research Report on Alcohol Drinking
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder Sunobinop, Placebo to match sunobinop - Alcohol Use Disorder | Phase 2 | Completed | Knoa Pharma LLC | 209 | 2024-10-14 | 2026-06-05 |
| Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink β-nicotinamide Mononucleotide, Maltodextrin - Binge Drinking, Liver Injury | Phase 1 / Phase 2 | Completed | Zhejiang Chinese Medical University | 22 | 2024-05-01 | 2025-04-10 |
| Semaglutide Therapy for Alcohol Reduction - Tulsa Semaglutide, Placebo - Alcohol Use Disorder | Phase 2 | Completed | Oklahoma State University Center for Health Sciences | 80 | 2023-07-07 | 2025-12-17 |
| Probiotics, Immune Function, and the Brain in Alcohol Consumers Seed DS-01 Daily Synbiotic - Alcohol; Use, Problem | Phase 2 | Completed | Brown University | 32 | 2022-02-24 | 2024-09-19 |
| Human Laboratory Study of ASP8062 for Alcohol Use Disorder ASP8062, Placebo - Alcohol Use Disorder, Alcohol Drinking | Phase 2 | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 60 | 2021-12-13 | 2024-12-03 |
| Opioid Modulation and Neural Reward Activation in Healthy Adults Naltrexone, Placebo - Alcohol Drinking, Opioid Use, Unspecified | Phase 1 / Phase 2 | Completed | University of Colorado, Denver | 13 | 2021-05-01 | 2023-11-28 |
| Role of BP1.3656 on Alcohol Responses BP1.3656, Placebo - Alcohol Use Disorder | Phase 2 | Completed | Centre for Addiction and Mental Health | 37 | 2021-02-01 | 2023-04-05 |
| St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Gabapentin Low-dose naltrexone, Gabapentin, Placebo - Chronic Pain, Alcohol Use, Unspecified | Phase 2 | Completed | Boston Medical Center | 45 | 2021-01-25 | 2022-11-10 |
| Timing Personalized Feedback After Alcohol Health Education e-checkup to go, Feedback booster - College Student Drinking | Phase 1 / Phase 2 | Completed | Abby Braitman | 195 | 2020-11-30 | 2023-05-03 |
| St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene Low dose naltrexone, Nalmefene - HIV Infection, Alcohol Use | Phase 1 / Phase 2 | Completed | Boston Medical Center | 11 | 2018-07-03 | 2020-08-24 |
| Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals With Alcohol Use Disorder GET73, Placebo - Alcohol Use Disorder | Phase 2 | Completed | Laboratorio Farmaceutico Ct S.r.l. | 24 | 2018-03-08 | 2020-10-08 |
| Personalized Booster Feedback After Alcohol Health Education e-checkup to go, Feedback-only booster, Feedback-plus-personal-contact booster - College Student Drinking | Phase 1 / Phase 2 | Completed | Abby Braitman | 249 | 2018-02-19 | 2022-06-30 |
| Alkontrol-herbal Effects on Alcohol Drinking kudzu extract, puerarin, Placebo control - Alcohol Drinking, Alcohol Use Disorder | Phase 2 | Completed | Mclean Hospital | 28 | 2018-01-01 | 2020-07-29 |
| Neuroscience-Informed Treatment Development for Adolescent Alcohol Use N-Acetylcysteine, Placebo Oral Capsule - Alcohol Drinking, Control | Phase 2 | Completed | Medical University of South Carolina | 57 | 2017-10-16 | 2023-06-22 |
| Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV) Varenicline, Cytisine, Nicotine Replacement Therapy - HIV Infection, Alcohol Use | Phase 2 / Phase 3 | Completed | Boston Medical Center | 400 | 2017-07-19 | 2020-12-17 |
| Oxytocin, Alcohol Craving, and Intimate Partner Aggression Oxytocin, Placebo - Alcohol Use | Phase 2 | Completed | Medical University of South Carolina | 200 | 2017-07-01 | 2022-05-09 |
| Saracatinib and Alcohol Drinking Saracatinib, Placebos - Alcohol Drinking | Phase 2 | Completed | Yale University | 50 | 2017-05-09 | 2020-11-13 |
| Alcohol Health Education With Personalized Feedback Boosters e-checkup to go, Norms-only booster, Norms-plus-Strategies booster - College Student Drinking | Phase 1 / Phase 2 | Completed | Abby Braitman | 528 | 2017-04-11 | 2023-06-22 |
| Marijuana's Impact on Alcohol Motivation and Consumption THC 7.2%, THC 3.1%, Placebo - Alcohol Drinking, Marijuana | Phase 2 | Completed | Brown University | 157 | 2017-01-23 | 2026-04-21 |
| Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home Motivation Enhancement Therapy, Modified Behavioral Self-Control Therapy, Naltrexone - Alcohol-Related Disorders, Alcohol Drinking | Phase 1 / Phase 2 | Completed | Northwell Health | 27 | 2017-01-01 | 2023-10-30 |
Showing 20 of 55. Sign in to see all of them.
Alcoholism (23) · Alcohol-Related Disorders (5) · Behavior, Addictive (5) · Binge Drinking (5) · Depression (5) · Substance-Related Disorders (5) · HIV Infections (4) · Alcohol Drinking in College (3) · Anxiety Disorders (3) · Drinking Behavior (3) · Smoking (3) · Smoking Cessation (3) · Alcoholic Intoxication (2) · Cigarette Smoking (2)
Behavior (55) · Drinking Behavior (52) · Mental Disorders (32) · Chemically-Induced Disorders (31) · Substance-Related Disorders (27) · Alcohol-Related Disorders (23) · Behavioral Symptoms (6) · Pathological Conditions, Signs and Symptoms (6) · Compulsive Behavior (5) · Impulsive Behavior (5) · Signs and Symptoms (5) · Urogenital Diseases (5) · Blood-Borne Infections (4) · Communicable Diseases (4)
Naltrexone (8) · Ethanol (6) · Varenicline (5) · Baclofen (2) · Bupropion (2) · Crisis Intervention (2) · Sugars (2) · Tobacco Use Cessation Devices (2) · 1-(((alpha-isobutanoyloxyethoxy)carbonyl)aminomethyl)-1-cyclohexaneacetic acid (1) · ASP8062 (1) · Acetylcysteine (1) · Counseling (1) · Cyproheptadine (1) · Ecological Momentary Assessment (1) · Gabapentin (1)
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (7) · Yale University (7) · Boston Medical Center (4) · Brown University (4) · Abby Braitman (3) · Centers for Disease Control and Prevention (2) · Mclean Hospital (2) · Medical University of South Carolina (2) · Boston University (1) · Centre for Addiction and Mental Health (1) · Danish Cancer Society (1) · Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH (1) · Iowa City Veterans Affairs Medical Center (1) · King's College London (1) · Knoa Pharma LLC (1)
United States (46) · Russia (3) · Canada (1) · China (1) · Denmark (1) · Germany (1) · Romania (1) · South Africa (1) · United Kingdom (1)
Abby L Braitman, Ph.D. (3) · Sherry A McKee, PhD (3) · Jeffrey H. Samet, MD, MA, MPH (2) · Lorenzo Leggio, M.D. (2) · Suchitra Krishnan-Sarin, Ph.D. (2) · Allen Zweben, PhD (1) · Bernhard Croissant, MD PhD (1) · Christoffer Johansen, M.D., Ph.D. (1) · Elizabeth J. D'Amico, PhD (1) · Glenn-Milo Santos, PhD (1) · James Garbutt (1) · Jane Metrik, PhD (1) · Jeffrey H Samet, MA, MA, MPH (1) · Jiaomei Li (1) · Joanne E Fertig, Ph.D. (1)
PMID 41329966, PMID 20048226, PMID 20732631, PMID 20869813, PMID 21134017, PMID 22324516, PMID 22592966, PMID 23262301, PMID 23265707, PMID 23282113, PMID 24766757, PMID 24814717, PMID 25086446, PMID 25752972, PMID 25888856, PMID 26048637, PMID 26254687, PMID 26675247, PMID 26946991, PMID 27062270, PMID 27535024, PMID 27936818, PMID 28440812, PMID 29133954, PMID 29261824, PMID 29389170, PMID 29843074, PMID 30817018, PMID 30865304, PMID 33682527, PMID 34081487, PMID 34766785, PMID 35930287, PMID 37142273, PMID 37530456, PMID 38408060, PMID 40392716, PMID 41129363, PMID 41254853, PMID 42400312
K01AA023849 (3), P50AA012870 (3), R01AA015596 (2), 1DP5OD019809 (1), K23AA025399 (1), P01AA019072 (1), P60AA013759 (1), R01AA012518 (1), R01AA013895 (1), R01AA013990 (1), R01AA018076 (1), R01AA020388 (1), R01AA022285 (1), R01AA024091 (1), R21AA023368 (1)